
Primary Prevention of Cardiovascular Diseases
Learn aspirin & statin use in CVD prevention. Evaluate risks, benefits. Stay updated with evidence-based dosing. Make informed recommendations.

About this course
The use of low-dose aspirin especially in elderly patients as a primary prevention strategy needs to be balanced with a potential risk of adverse events, such as bleeding. In the past, a low dose of aspirin was recommended to prevent stroke and myocardial infarction. However, recent evidence indicates that aspirin use in patients with low to moderate risk of cardiovascular diseases (CVD) is not associated with a reduction in CVD. Rather, it presents with an increased risk of bleeding. The use of statin in patients at risk of CVD has evolved with recent evidence recommending the use of pooled cohort equation to calculate 10-year Atherosclerotic Cardiovascular Disease (ASCVD) risk when determining if a patient can benefit from statin use as a primary prevention strategy. Evidence from the latest clinical trials will be presented to assist the participating audience in determining when the use of low-dose aspirin and statin is recommended. Healthcare professionals will be able to make recommendations to de-prescribe inappropriate use of low-dose aspirin where no added benefit is shown. The use of statin with its correct dosing will be reviewed allowing healthcare professionals to calculate 10-year ASCVD risk to guide decision making.
Course Accreditation
Instructors

Dr. Patel is an associate professor of pharmacy practice at the School of Pharmacy and Health Sciences at Fairleigh Dickinson University (FDU). She is a board certified pharmacotherapy specialist and her specialty is in cardiovascular pharmacotherapy. She worked with a team of interdisciplinary healthcare professionals in the cardiac care unit for Mt. Sinai St. Luke’s Hospital. She is an associate editorial team lead for the American College of Cardiology-Geriatric Cardiology topical collection and the cardiology section editor for APhA’s Pharmacotherapy First disease state modules. She has published her work in various pharmacy and medical journals and presented at several state and national conferences.​
You might also be interested in


Characteristics of Future Models of Integrated Outpatient Care
2 hoursCharacteristics of Future Models of Integrated Outpatient Care
Learn about emerging models of integrated outpatient care, focusing on innovative approaches to improving patient outcomes, efficiency, and collaboration in the evolving healthcare system.
View full details of Characteristics of Future Models of Integrated Outpatient CarePrice: $18.00
Duration: 2 hours


Clinical Manifestation & Management of Parkinson's Disease
1 hourClinical Manifestation & Management of Parkinson's Disease
Learn to manage Parkinson’s disease medications effectively with this activity. Refresh your understanding of its pathophysiology, drug targets, classes of antiparkinson's drugs, clinical use, and adverse effects.
View full details of Clinical Manifestation & Management of Parkinson's DiseasePrice: $10.50
Duration: 1 hour


Exploring Psilocybin: Advancements in Understanding, Therapeutic Applications, and Pharmacist Responsibilities
1 hourExploring Psilocybin: Advancements in Understanding, Therapeutic Applications, and Pharmacist Responsibilities
Learn the science, benefits, risks, and legal landscape of psilocybin, equipping you to navigate its therapeutic potential and engage in informed discussions with patients and healthcare teams.
View full details of Exploring Psilocybin: Advancements in Understanding, Therapeutic Applications, and Pharmacist ResponsibilitiesPrice: $10.00
Duration: 1 hour


Rheumatoid Arthritis Across the Lifespan: Evidence-Based Approaches for Primary and Specialty Care
3 hoursRheumatoid Arthritis Across the Lifespan: Evidence-Based Approaches for Primary and Specialty Care
Learn to recognize, diagnose, and manage rheumatoid arthritis with updated guidelines, treatment strategies, and tools for improving outcomes and promoting equitable, patient-centered care.
View full details of Rheumatoid Arthritis Across the Lifespan: Evidence-Based Approaches for Primary and Specialty CarePrice: $15.00
Duration: 3 hours
See why 500k+ healthcare professionals trust us with their renewal
Real reviews, real results
Get total access with AchieveCE
Get unlimited CE for one low annual fee. Save time and money by becoming a member.
